Development of protein microarray technology to monitor biomarkers of rheumatoid arthritis disease

Cell Biology and Toxicology

Volumn 19, Issue 3, 2003, Pages 189-202

  Urbanowska, Teresa ^a   Mangialaio, S ^a   Hartmann, C ^a   Legay, F ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Antibodies; Immunoassay; Protein microarray; Rheumatoid arthritis; Self assembled monolayer

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; ORGANOPHOSPHATE; POLYLYSINE; PROTEIN; SERUM AMYLOID A;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; DNA MICROARRAY; DOSE RESPONSE; FLUOROSCOPY; HUMAN; IMMUNOLOGY; INSTRUMENTATION; METABOLISM; METHODOLOGY; PIEZOELECTRICITY; PRIORITY JOURNAL; PROTEIN MICROARRAY; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SIGNAL DETECTION; SIGNAL NOISE RATIO; SURFACE PROPERTY;

ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; PROTEIN ARRAY ANALYSIS; PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SURFACE PROPERTIES;

EID: 0042527534     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024729526867     Document Type: Article

References (28)

1. Arvidson NG, Gudbjornsson B, Elfman L, Ryden AC, Totterman TH, Hallgren R. Circadian rhythm of serum interleukin-6 in rheumatoid arthritis. Ann Rheum Dis. 1994;53: 521-4.
2. Bates DL. Enzyme amplified immunoassays. Ann Biol Clin (Paris). 1989;47:527-32.
3. Bowsher RR, Smith WC. Analytical validation of assays for novel biomarkers. AAPS Newsmagazine. 2002;6:18-25.
4. Brovelli D, Hähner G, Ruiz L et al. Highly oriented, self-assembled alkanephosphate monolayers on tantalum (V) oxide surfaces. Langmuir. 1999;15:4324-7.
5. Charles P, Elliott MJ, Davis D et al. Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis. J Immunol. 1999;163:1521-8.
6. Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med. 2001;344:907-16.
7. Corthals GL, Wasinger VC, Hochstrasser DF, Sanchez JC. The dynamic range of protein expression: a challenge for proteomic research. Electrophoresis. 2000;21:1104-15.
8. Cunnane G, Grehan S, Geoghegan S et al. Serum amyloid A in the assessment of early inflammatory arthritis. J Rheumatol. 2000;27:58-63.
9. Daniels MA, Hogquist KA, Jameson SC. Sweet 'n' sour: the impact of differential glycosylation on T cell responses. Nat Immunol. 2002;3:903-10.
10. De Benedetti F, Pignatti P, Bernasconi S et al. Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes. J Rheumatol. 1999; 26:425-31.
11. Griffin TJ, Han DK, Gygi SP et al. Toward a high-throughput approach to quantitative proteomic analysis: expression-dependent protein identification by mass spectrometry. J Am Soc Mass Spectrom. 2001;12:1238-46.
12. Gygi SP, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol. 1999;19:1720-30.
13. Haab BB. Advances in protein microarray technology for protein expression and interaction profiling. Curr Opin Drug Discov Dev. 2001;4:116-23.
14. Haab BB, Dunham MJ, Brown PO. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol. 2001;2:1-13.
15. Han KK, Martinage A. Post-translational chemical modifications of proteins-III. Current developments in analytical procedures of identification and quantitation of post-translational chemically modified amino acid(s) and its derivatives. Int J Biochem. 1993;25:957-70.
16. Ideker T, Ozier O, Schwikowski B, Siegel AF. Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics. 2002;18(Supplement 1):S233-40.
17. Kodadek T. Protein microarrays: prospects and problems. Chem Biol. 2001;8:105-15.
18. Lander ES, Linton LM, Birren B et al. Initial sequencing and analysis of the human genome. Nature. 2001;409:860-921.
19. Lian Z, Kluger Y, Greenbaum DS et al. Genomic and proteomic analysis of the myeloid differentiation program: global analysis of gene expression during induced differentiation in the MPRO cell line. Blood. 2002;100:3209-20.
20. Lipsky PE. Rheumatoid arthritis. In: Harrison TR, ed. Harrison's principles of internal medicine. Disorders of immune-mediated injury. New York: McGraw-Hill. 1998: 1880-8.
21. Lockhart DJ, Dong H, Byrne MC et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol. 1996;14:1675-80.
22. MacBeath G, Schreiber SL. Printing proteins as microarrays for high-throughput function determination. Science. 2000;289:1760-3.
23. Neuschäfer D, Budach W, Wanke C. Evanescent resonator chips: a universal platform with superior sensitivity for fluorescence-based microarrays. Biosensors Bioelectronics. 2003;18:489-97.
24. Schena M. Microfluidic technologies and instrumentation for printing DNA microarrays. In: Schena M, ed. Microarray biochip technology. Natick, MA: Eaton Publishing; 2000:19-38.
25. Schwikowski B, Uetz P, Fields S. A network of protein-protein interactions in yeast. Nat Biotechnol. 2000;18:1257-61.
26. Shevchenko A, Loboda A, Shevchenko A, Ens W, Standing KG. MALDI quadrupole time-of-flight mass spectrometry: a powerful tool for proteomic research. Anal Chem. 2000;72:2132-41.
27. Stoll D, Templin MF, Schrenk M, Traub PC, Vohringer CF, Joos TO. Protein microarray technology. Front Biosci. 2002; 7:c13-32.
28. Venter JC, Adams MD, Myers EW et al. The sequence of the human genome. Science. 2001;291:1304-51.